Manuscript Updates
- Update from Lydia and Lauren
- Status of manuscript submitted to Endocrine Practice
White Paper Revisions
- Review revisions to the White Paper in light of stage 3 teplizumab clearance
- Divide into 5-6 groups based on subsections
- Getting Ahead of Type 1 Diabetes
Review proposed Screening and Monitoring questions for the annual survey
- The T1DX-QI Annual Survey will go live on August 17th. Survey information will be shared with center PIs and coordinators. One survey should be completed by each center by October 1st. Specific dates will be shared soon.
- T1D Screening, Staging, and Monitoring section feedback was shared
Brainstorm Stage 3 implementation across the Collaborative as a funded intervention supported by Sanofi:
- Stage 3 implementation at the six pediatric centers that participated in the earlier Screening and Monitoring project
- Opportunities for spreading screening and monitoring across Collaborative centers that have not previously participated in the intervention